Literature DB >> 25743373

Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.

I Mangas1,2,3, P Taylor4, E Vilanova5, J Estévez5, T C C França6,7, E Komives8, Z Radić4.   

Abstract

The hydroxyl oxygen of the catalytic triad serine in the active center of serine hydrolase acetylcholinesterase (AChE) attacks organophosphorus compounds (OPs) at the phosphorus atom to displace the primary leaving group and to form a covalent bond. Inhibited AChE can be reactivated by cleavage of the Ser-phosphorus bond either spontaneously or through a reaction with nucleophilic agents, such as oximes. At the same time, the inhibited AChE adduct can lose part of the molecule by progressive dealkylation over time in a process called aging. Reactivation of the aged enzyme has not yet been demonstrated. Here, our goal was to study oxime reactivation and aging reactions of human AChE inhibited by mipafox or a sarin analog (Flu-MPs, fluorescent methylphosphonate). Progressive reactivation was observed after Flu-MPs inhibition using oxime 2-PAM. However, no reactivation was observed after mipafox inhibition with 2-PAM or the more potent oximes used. A peptide fingerprinted mass spectrometry (MS) method, which clearly distinguished the peptide with the active serine (active center peptide, ACP) of the human AChE adducted with OPs, was developed by MALDI-TOF and MALDI-TOF/TOF. The ACP was detected with a diethyl-phosphorylated adduct after paraoxon inhibition, and with an isopropylmethyl-phosphonylated and a methyl-phosphonylated adduct after Flu-MPs inhibition and subsequent aging. Nevertheless, nonaged nonreactivated complexes were seen after mipafox inhibition and incubation with oximes, where MS data showed an ACP with an NN diisopropyl phosphoryl adduct. The kinetic experiments showed no reactivation of activity. The computational molecular model analysis of the mipafox-inhibited hAChE plots of energy versus distance between the atoms separated by dealkylation showed a high energy demand, thus little aging probability. However, with Flu-MPs and DFP, where aging was observed in our MS data and in previously published crystal structures, the energy demand calculated in modeling was lower and, consequently, aging appeared as a more likely reaction. We document here direct evidence for a phosphorylated hAChE refractory to oxime reactivation, although we observed no aging.

Entities:  

Keywords:  Acetylcholinesterase; Aging; Mipafox; Organophosphorus compounds; Oximes; Sarin

Mesh:

Substances:

Year:  2015        PMID: 25743373      PMCID: PMC4833118          DOI: 10.1007/s00204-015-1481-1

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  22 in total

1.  Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.

Authors:  P Masson; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry.

Authors:  Melanie J Schroeder; Jeffrey Shabanowitz; Jae C Schwartz; Donald F Hunt; Joshua J Coon
Journal:  Anal Chem       Date:  2004-07-01       Impact factor: 6.986

3.  Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.

Authors:  C B Millard; G Kryger; A Ordentlich; H M Greenblatt; M Harel; M L Raves; Y Segall; D Barak; A Shafferman; I Silman; J L Sussman
Journal:  Biochemistry       Date:  1999-06-01       Impact factor: 3.162

4.  Reactivation of phosphorodiamidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride.

Authors:  D Milatovic; M K Johnson
Journal:  Chem Biol Interact       Date:  1993-06       Impact factor: 5.192

Review 5.  The cholinesterases: from genes to proteins.

Authors:  P Taylor; Z Radić
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

6.  Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry.

Authors:  Lori L Jennings; Michael Malecki; Elizabeth A Komives; Palmer Taylor
Journal:  Biochemistry       Date:  2003-09-23       Impact factor: 3.162

Review 7.  Mammalian toxicology of organophosphorus pesticides.

Authors:  L G Sultatos
Journal:  J Toxicol Environ Health       Date:  1994-11

8.  Direct observation and elucidation of the structures of aged and nonaged phosphorylated cholinesterases by 31P NMR spectroscopy.

Authors:  Y Segall; D Waysbort; D Barak; N Ariel; B P Doctor; J Grunwald; Y Ashani
Journal:  Biochemistry       Date:  1993-12-14       Impact factor: 3.162

9.  Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin.

Authors:  L W Harris; J H Fleisher; J Clark; W J Cliff
Journal:  Science       Date:  1966-10-21       Impact factor: 47.728

10.  Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification.

Authors:  Rakesh K Sit; Valery V Fokin; Gabriel Amitai; K Barry Sharpless; Palmer Taylor; Zoran Radić
Journal:  J Med Chem       Date:  2014-02-07       Impact factor: 7.446

View more
  2 in total

1.  The inhibition, reactivation and mechanism of VX-, sarin-, fluoro-VX and fluoro-sarin surrogates following their interaction with HuAChE and HuBuChE.

Authors:  Chih-Kai Chao; Narayanaganesh Balasubramanian; John M Gerdes; Charles M Thompson
Journal:  Chem Biol Interact       Date:  2018-06-18       Impact factor: 5.192

2.  Immunopurification of Acetylcholinesterase from Red Blood Cells for Detection of Nerve Agent Exposure.

Authors:  Alicia J Dafferner; Lawrence M Schopfer; Gaoping Xiao; John R Cashman; Udaya Yerramalla; Rudolph C Johnson; Thomas A Blake; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2017-09-25       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.